Aliases & Classifications for Bronchial Disease

MalaCards integrated aliases for Bronchial Disease:

Name: Bronchial Disease 12 15
Bronchial Diseases 55 44 73
Bronchial Disorders 43
Bronchial Spasm 73
Bronchospasm 12

Classifications:



External Ids:

Disease Ontology 12 DOID:1176
MeSH 44 D001982
SNOMED-CT 68 41427001

Summaries for Bronchial Disease

MedlinePlus : 43 When you breathe in, the air travels down through your trachea (windpipe). It then goes through two tubes to your lungs. These tubes are your bronchi. Bronchial disorders can make it hard for you to breathe. The most common problem with the bronchi is bronchitis, an inflammation of the tubes. It can be acute or chronic. Other problems include Bronchiectasis - a condition in which damage to the airways causes them to widen and become flabby and scarred Exercise-induced bronchospasm - a breathing problem that happens when your airways shrink while you are exercising Bronchiolitis - an inflammation of the small airways that branch off from the bronchi Bronchopulmonary dysplasia - a chronic lung condition in infants, most often premature infants

MalaCards based summary : Bronchial Disease, also known as bronchial diseases, is related to bronchitis and pulmonary tuberculosis, and has symptoms including apnea, coughing and dyspnea. An important gene associated with Bronchial Disease is ELANE (Elastase, Neutrophil Expressed), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Budesonide and Amikacin have been mentioned in the context of this disorder. Affiliated tissues include lung, testes and t cells, and related phenotypes are hematopoietic system and homeostasis/metabolism

Disease Ontology : 12 A lower respiratory tract disease that affects the airways leading into the lungs, which is caused due to inflammation of the bronchi and bronchioles, infection, or blockage.

Related Diseases for Bronchial Disease

Diseases related to Bronchial Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 179)
# Related Disease Score Top Affiliating Genes
1 bronchitis 32.5 CCL11 CXCL8 ELANE IL5 RNASE3 TNF
2 pulmonary tuberculosis 31.0 IFNGR1 IL4 TLR9 TNF
3 gastroesophageal reflux 30.5 CXCL8 IL5 TRPV1
4 colitis 30.4 CXCL8 IL4 TLR9 TNF
5 interstitial lung disease 30.2 CXCL8 IL4 TNF
6 lung disease 30.2 CXCL8 ELANE IL13 IL5 TLR9 TNF
7 bronchiolitis 29.7 CCL11 CXCL8 IL13 IL4 IL5 RNASE3
8 asthma 29.5 ADAM33 ADRB2 AREG CCL11 CXCL8 CYSLTR1
9 cytokine deficiency 11.1 IL13 IL5
10 paragonimiasis 11.1 IL13 IL5 RNASE3
11 apple allergy 11.1 IL13 IL4 IL5
12 intrinsic asthma 11.1 IL4 IL5 RNASE3
13 atopic keratoconjunctivitis 11.1 IL4 IL5 RNASE3
14 strongyloidiasis 11.1 CCL11 IL13 IL5
15 tropical endomyocardial fibrosis 11.1 IL4 TNF
16 blepharoconjunctivitis 11.1 CCL11 IL4 RNASE3
17 chronic tic disorder 11.1 IL13 IL4 IL5
18 angioimmunoblastic lymphadenopathy with dysproteinemia 11.1 IL13 IL5 TNF
19 eosinophilic gastroenteritis 11.1 CCL11 IL5 RNASE3
20 chronic eosinophilic pneumonia 11.1 CCL11 IL5 RNASE3
21 folliculitis 11.1 CCL11 IL4 IL5
22 enterobiasis 11.0 IL13 IL4 IL5
23 night blindness, congenital stationary, type 1a 11.0 CCL11 IL13 IL5
24 ascaris lumbricoides infection 11.0 IL13 IL5 TSLP
25 loeffler endocarditis 11.0 IL5 RNASE3
26 scleritis 11.0 IL4 IL5 TNF
27 mycobacterium fortuitum 11.0 CXCL8 IFNGR1
28 milk allergy 11.0 IL4 IL5 RNASE3
29 pustulosis palmaris et plantaris 11.0 ELANE IL5 TNF
30 pemphigoid gestationis 11.0 CCL11 IL5
31 nut allergy 11.0 IL5 STAT6 TLR9
32 beta-lactam allergy 11.0 IL13 IL4 STAT6
33 coccidiosis 11.0 IL4 TLR9 TNF
34 lichen disease 11.0 IL4 TLR9 TNF
35 papillary conjunctivitis 11.0 CCL11 CXCL8 IL4
36 cellulitis 11.0 IL5 RNASE3 TNF
37 primary amebic meningoencephalitis 11.0 IL4 IL5 STAT6
38 cardiac rupture 11.0 CXCL8 ELANE FLNC
39 extrinsic cardiomyopathy 11.0 IL4 TLR9 TNF
40 vernal conjunctivitis 11.0 IL4 MS4A2 RNASE3
41 cough variant asthma 11.0 IL4 IL5 RNASE3 TRPV1
42 aspergillosis 11.0 ELANE IL4 IL5 TLR9
43 churg-strauss syndrome 11.0 IL5 RNASE3 TNF
44 tungiasis 11.0 CXCL8 IL4 TNF
45 keratoconjunctivitis sicca 11.0 IL4 TLR9 TNF
46 inflammatory bowel disease 4 11.0 IL13 IL4 IL5 RNASE3
47 wells syndrome 11.0 CXCL8 IL5 RNASE3
48 bronchopulmonary dysplasia 11.0 CXCL8 ELANE RNASE3
49 trichuriasis 11.0 CXCL8 IL13 TNF
50 latex allergy 11.0 IL13 IL4 IL5 RNASE3

Graphical network of the top 20 diseases related to Bronchial Disease:



Diseases related to Bronchial Disease

Symptoms & Phenotypes for Bronchial Disease

UMLS symptoms related to Bronchial Disease:


apnea, coughing, dyspnea, snoring, wheezing, inspiratory wheeze, expiratory wheeze

MGI Mouse Phenotypes related to Bronchial Disease:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.21 IL4 TLR9 ELANE TNF IL5 IFNGR1
2 homeostasis/metabolism MP:0005376 10.17 TLR9 IL4 ELANE FLNC TNF IL5
3 immune system MP:0005387 10.16 TLR9 CYSLTR1 ELANE TNF IL5 IFNGR1
4 digestive/alimentary MP:0005381 10.06 TLR9 IL4 TNF IL5 IFNGR1 IL13
5 integument MP:0010771 9.85 IL4 FLNC TNF IFNGR1 TRPV1 IL13
6 no phenotypic analysis MP:0003012 9.5 IL4 TNF TRPV1 ADAM33 IL13 ADRB2
7 respiratory system MP:0005388 9.32 IL4 CYSLTR1 FLNC TNF IL5 IL13

Drugs & Therapeutics for Bronchial Disease

Drugs for Bronchial Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 652)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Budesonide Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 51333-22-3 63006 5281004
2
Amikacin Approved, Investigational, Vet_approved Phase 4,Phase 1,Phase 2,Not Applicable 37517-28-5 37768
3
Tobramycin Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 32986-56-4 5496 36294
4
Acetylcysteine Approved, Investigational Phase 4,Phase 2,Not Applicable 616-91-1 12035
5
Bromhexine Approved Phase 4 3572-43-8
6
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-43-4 5816
7
Racepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 329-65-7 838
8
Nitric Oxide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 10102-43-9 145068 160954
9
Ipratropium Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 22254-24-6, 60205-81-4 43232
10
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 7487-88-9 24083
11
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83-43-2 6741
12
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-24-8 5755
13
Atracurium Approved, Experimental, Investigational Phase 4 64228-79-1 47319
14
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 1994-09-7, 94-09-7 2337
15
Cisatracurium Approved Phase 4 96946-41-7
16
Dexmedetomidine Approved, Vet_approved Phase 4 113775-47-6 68602 5311068
17
Etomidate Approved Phase 4 33125-97-2 36339 667484
18
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 437-38-7 3345
19
Midazolam Approved, Illicit Phase 4,Phase 1 59467-70-8 4192
20
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 2078-54-8 4943
21
Remifentanil Approved Phase 4 132875-61-7 60815
22
Montelukast Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 158966-92-8 5281040
23
Bambuterol Approved, Investigational Phase 4 81732-65-2, 81732-46-9 54766
24
Terbutaline Approved Phase 4,Phase 3,Phase 2,Not Applicable 23031-25-6 5403
25
Ephedrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 299-42-3 9294
26
Guaifenesin Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 93-14-1 3516
27
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 90-82-4 7028
28
Procaterol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 72332-33-3 688561
29
Fluticasone Approved, Experimental, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 90566-53-3 62924
30
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 53-03-2 5865
31
Dexlansoprazole Approved, Investigational Phase 4,Phase 3 138530-94-6, 103577-45-3 9578005
32
Lansoprazole Approved, Investigational Phase 4,Phase 3 103577-45-3 3883
33
Azithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83905-01-5 55185 447043
34
Levofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 100986-85-4 149096
35
Ofloxacin Approved Phase 4,Phase 3,Phase 2,Not Applicable 82419-36-1 4583
36
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-02-2 5743
37
Omalizumab Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 242138-07-4
38
Menthol Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 2216-51-5 16666
39
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 75614-87-8, 51-45-6 774
40
Ciclesonide Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 126544-47-6, 141845-82-1 444033
41
Citalopram Approved Phase 4,Not Applicable 59729-33-8 2771
42
Hydrocortisone Approved, Vet_approved Phase 4,Phase 2,Phase 1 50-23-7 5754
43
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-78-2 2244
44
Theophylline Approved Phase 4,Phase 3,Phase 2 58-55-9 2153
45
Aztreonam Approved Phase 4,Phase 3,Phase 2 78110-38-0 5362041 5742832
46
Erythromycin Approved, Investigational, Vet_approved Phase 4 114-07-8 12560
47
Mechlorethamine Approved, Investigational Phase 4,Phase 3,Phase 2 51-75-2 4033
48
Telithromycin Approved Phase 4,Phase 3 191114-48-4 5462516 0
49
Varenicline Approved, Investigational Phase 4 249296-44-4 5310966
50
Cetirizine Approved Phase 4,Phase 3 83881-51-0 2678

Interventional clinical trials:

(show top 50) (show all 2979)
# Name Status NCT ID Phase Drugs
1 Comparisons of Inhaled LAMA or ICS+LABA for COPD With Bronchiectasis Unknown status NCT02546297 Phase 4 Symbicort;Tiotropium Bromide
2 Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of Bronchiectasis Unknown status NCT02509091 Phase 4 Bronchoalveolar Lavage and Local Amikacin Injection
3 Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis Unknown status NCT02507843 Phase 4 Cholecalciferol;Placebo
4 A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With Bronchiectasis Unknown status NCT01677403 Phase 4 Tobramycin;Saline
5 Effect of Long-term, High-dose N-acetylcysteine on Exacerbations of Bronchiectaisis Unknown status NCT02088216 Phase 4 N-acetylcysteine;Placebo
6 Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis Unknown status NCT02081963 Phase 4 Amikacin;Normal saline
7 Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography Unknown status NCT01361984 Phase 4 Nebulized arformoterol;Salmeterol
8 Effect of Vitamin D Supplementation in Young South African Children Hospitalized With Acute Lower Respiratory Infection Unknown status NCT02054182 Phase 4 Vitamin D
9 Home Oxygen Therapy in Bronchiolitis Unknown status NCT01216553 Phase 4
10 Bronchiolitis All-study, SE-Norway Unknown status NCT00817466 Phase 4 Racemic adrenaline;Isotonic saline
11 Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pulmonary Disease (COPD) Phenotype Unknown status NCT01431625 Phase 4
12 Treatment Efficacy of Budesonide/Formoterol in Cough Variant Asthma and Typical Asthma Patients Unknown status NCT02934945 Phase 4 budesonide 160μg/formoterol 4.5μg
13 Low Exhaled NO and ICS in Suspected Asthma Unknown status NCT02771717 Phase 4 Budesonide (Pulmicort);Placebo - dummy inhaler
14 Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation Unknown status NCT02584738 Phase 4 Nebulized Magnesium Sulfate;Nebulized isotonic saline;Nebulized Salbutamol;Ipratropium bromide;Methylprednisolone or Prednisolone
15 Extra-fine Formoterol/Beclomethasone in Asthmatic Crisis Unknown status NCT02345993 Phase 4 Extra fine Formoterol/Beclomethasone
16 Effect of Dexmedetomidine on Levels of Plasma Inflammatory Factor in Asthma Patients Undergoing General Anesthesia Unknown status NCT02289391 Phase 4 Anesthesia induction;Anesthesia maintenance;Assisted anesthesia
17 Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus Surgery Unknown status NCT02110654 Phase 4 Montelukast;mometasone furoate nasal spray
18 Effect of Vitamin D Supplementation on the Control of Asthma in Children at a South African Academic Hospital Unknown status NCT02053402 Phase 4 Vitamin D
19 Efficacy of Bronchial Thermoplasty in Korean Unknown status NCT02031263 Phase 4
20 The Effect of Bronchodilator on Eosinophilic Bronchitis and Cough Variant Asthma Unknown status NCT02002754 Phase 4 Bambuterol Hydrochloride tablets
21 Therapeutic Effect of Different Treatment Course With Inhaled Corticosteroids in Eosinophilic Bronchitis Patients Unknown status NCT02002715 Phase 4 Inhaled budesonide
22 Efficacy and Safety of Activation Energy Serum (AES) Versus Placebo in Persistent Asthma. Unknown status NCT01939951 Phase 4
23 Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at Home Unknown status NCT01783132 Phase 4
24 Effects of Su-Huang Antitussive Capsule on Cough Variant Asthma Unknown status NCT01584804 Phase 4 Su-Huang antitussive capsule;Sugar pill
25 Assessing Decision Maker Tools for Asthma: the Asthma APGAR Unknown status NCT01446315 Phase 4
26 Effects of Leukotriene Modulator Montelukast on Cough Variant Asthma Unknown status NCT01404013 Phase 4 ICS/LABA;Montelukast;ICS/LABA and Montelukast
27 Efficacy and Safety Study of Procaterol Hydrochloride to Treat Patients With Cough Variant Asthma (CVA) Unknown status NCT01170429 Phase 4 Procaterol hydrochloride;Meptin placebo
28 Efficacy and Safety of add-on Montelukast to Inhaled Budesonide in the Treatment of Nonasthmatic Eosinophilic Bronchitis Unknown status NCT01121016 Phase 4 Montelukast
29 Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites Unknown status NCT01052610 Phase 4 sublingual house dust mites allergen extract;placebo in sublingual applicator
30 Concentrations of Salmeterol in Blood and Urine Unknown status NCT00914901 Phase 4 inhaled salmeterol
31 Terbutaline Concentrations in Blood and Urine Unknown status NCT00914797 Phase 4 inhaled and oral terbutaline
32 Concentrations of Formoterol in Blood and Urine Unknown status NCT00914654 Phase 4 inhaled formoterol
33 Rapid Onset Action of Salbutamol Versus Formoterol Unknown status NCT00900874 Phase 4 salbutamol;Formoterol
34 Fluticasone/Salmeterol (FP/SM) Versus Double the Dose Fluticasone (FP) in Patients With Mild to Moderate Asthma Unknown status NCT00830505 Phase 4 fluticasone/ salmeterol;fluticasone
35 Vitamin D for the Treatment of Severe Asthma Unknown status NCT00712205 Phase 4 Placebo;Calcitriol
36 A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start Children Unknown status NCT00624429 Phase 4 Budesonide respules
37 Inflammatory, Functional and Image Composite Measure to Define Asthma Control Unknown status NCT00597064 Phase 4 prednisone
38 Assessment of Utility of Exhaled Nitric Oxide Measurement for Treatment Monitoring in Children With Asthma Unknown status NCT00500253 Phase 4
39 Evaluation of Efficacy of House Dust Mite Immunotherapy in Children With Bronchial Asthma Unknown status NCT00496574 Phase 4
40 Effect of Specific Immunotherapy to Dust Mites in Children With Asthma Unknown status NCT00496561 Phase 4
41 Treatment of Acute Asthma in ER With Combination of Systemic Steroids and Inhaled Steroids Unknown status NCT00397267 Phase 4 inhalation of corticosteroids
42 A Pilot Efficacy Study of Inhaled Albuterol Delivered With Akita Breath Control Unknown status NCT00385359 Phase 4 Albuterol
43 A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy. Unknown status NCT00237068 Phase 4 Lansoprazole; Solutab
44 Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 Mcg BID Unknown status NCT00235053 Phase 4 fluticasone/salmeterol DISKUS 250/50
45 Airway Clearance for Prevention of COPD Exacerbation Unknown status NCT00181207 Phase 4
46 Duration of Antibiotic Therapy in Community - Acquired Pneumonia Unknown status NCT01492387 Phase 4
47 Impact of Continuous Positive Airway Pressure on the Treatment of Acute Asthma Exacerbation Completed NCT01403467 Phase 4
48 Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis Completed NCT02782312 Phase 4 ICS+LABA
49 Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm Completed NCT02182713 Phase 4 Salbutamol sulfate/Ipratropium bromide;Salbutamol
50 Efficacy of Azithromycin in Treatment of Bronchiectasis Completed NCT02107274 Phase 4 Azithromycin;Placebo for Azithromycin

Search NIH Clinical Center for Bronchial Disease

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: bronchial diseases

Genetic Tests for Bronchial Disease

Anatomical Context for Bronchial Disease

MalaCards organs/tissues related to Bronchial Disease:

41
Lung, Testes, T Cells, Heart, Neutrophil, Bone, Trachea

Publications for Bronchial Disease

Articles related to Bronchial Disease:

(show all 47)
# Title Authors Year
1
Male patient with chronic bronchial disease and bullous emphysema superinfection. ( 29703394 )
2018
2
Novel Mutation of Interferon-I^ Receptor 1 Gene Presenting as Early Life Mycobacterial Bronchial Disease. ( 27868075 )
2016
3
A case of IgG4-related bronchial disease successfully treated with inhaled corticosteroids. ( 26441152 )
2015
4
Progression and prognostic indicators of bronchial disease in children with sickle cell disease. ( 24699774 )
2014
5
Correlation of bronchoalveolar eosinophilic percentage with airway responsiveness in cats with chronic bronchial disease. ( 23617298 )
2013
6
'Heavier the interval than the consummation': bronchial disease in Sean O Riordain's diaries. ( 24002457 )
2013
7
Lower respiratory tract endoscopy in the cat: diagnostic approach to bronchial disease. ( 24152702 )
2013
8
Inhaled budesonide therapy in cats with naturally occurring chronic bronchial disease (feline asthma and chronic bronchitis). ( 24000786 )
2013
9
Use of propentofylline in feline bronchial disease: prospective, randomized, positive-controlled study. ( 20810552 )
2010
10
Radiographic abnormalities in cats with feline bronchial disease and intra- and interobserver variability in radiographic interpretation: 40 cases (1999-2006). ( 19210258 )
2009
11
Tobacco as an allergen in bronchial disease. ( 17458428 )
2007
12
The nose: gatekeeper and trigger of bronchial disease. ( 17020064 )
2006
13
Twenty-five cases of feline bronchial disease (1995-2000). ( 15135355 )
2004
14
Flexible bronchoscopy: a safe method for metal stent implantation in bronchial disease. ( 10735670 )
2000
15
The role of airway stents in the management of pediatric tracheal, carinal, and bronchial disease. ( 11053808 )
2000
16
Elastic deformation properties of implanted endobronchial wire stents in benign and malignant bronchial disease: A radiographic in vivo evaluation. ( 10094988 )
1999
17
Pneumocystis carinii infection in patients with chronic bronchial disease. ( 8598795 )
1996
18
Atypical bronchoplasty to lung cancer and benign bronchial disease. ( 8073432 )
1994
19
Broncholithiasis: a neglected bronchial disease in this country. Illustration of three cases. ( 1581838 )
1992
20
From alveoli back to bronchi. Contribution of bronchoalveolar (BAL) and bronchial (BL) lavage to the understanding of bronchial disease. International workshop. Verno, Italy, April 19-21, 1990. ( 1349762 )
1992
21
Cefetamet pivoxil (Ro 15-8075) and amoxicillin in the treatment of bacterial exacerbations of chronic bronchial disease--preliminary results. ( 16312635 )
1989
22
Clinical, radiographic, and bronchial cytologic features of cats with bronchial disease: 65 cases (1980-1986). ( 2470710 )
1989
23
Aspiration of solid food particles into lungs of patients with gastroesophageal reflux and chronic bronchial disease. ( 3338306 )
1988
24
Comparison of CT and fiberoptic bronchoscopy in the evaluation of bronchial disease. ( 3491497 )
1987
25
Beta-blockers and the patient with bronchial disease. ( 2879812 )
1986
26
Chronic bronchial disease of the cat. ( 3907110 )
1985
27
End-inspiratory flow reduction in the forced flow-volume curve as a sign of unilateral bronchial disease. ( 4080042 )
1985
28
Bronchial disease in ulcerative colitis. ( 7444824 )
1980
29
Quantitative sputum gram stains in chronic bronchial disease. ( 43418 )
1979
30
Manual and computer methods for measuring lung mechanics in children with bronchial disease. ( 752398 )
1978
31
Anaerobic bacteriology of chronic bronchial disease. With a refined method of sampling bronchial secretions. ( 588430 )
1977
32
Physical properties of sputum and respiratory function in chronic bronchial disease. ( 4778954 )
1973
33
Relationship of physical sputum characteristics and ventilatory capacity in chronic bronchial disease. ( 4695750 )
1973
34
Sputum cell dynamics in bacterial exacerbations of chronic bronchial disease. ( 5019450 )
1972
35
Anhidrotic ectodermal dysplasia: predisposition to bronchial disease. ( 5539281 )
1971
36
A BREATHING EXERCISE PROGRAM FOR CHRONIC BRONCHIAL DISEASE AND PULMONARY EMPHYSEMA. ( 14348275 )
1965
37
NATURAL HISTORY OF PLACEBO-TREATED PATIENTS WITH CHRONIC BRONCHIAL DISEASE OBSERVED FOR 7 YEARS. ( 14288021 )
1964
38
Sweat chloride in patients with chronic bronchial disease and its relation to mucoviscidosis (cystic fibrosis). ( 14021816 )
1963
39
EXPECTORANTS IN THE MANAGEMENT OF CHRONIC OBSTRUCTIVE BRONCHIAL DISEASE. ( 14084008 )
1963
40
SUPPRESSIVE THERAPY WITH ANTIBIOTICS IN PATIENTS WITH CHRONIC BRONCHIAL DISEASE AND HYPOGAMMAGLOBULINEMIA. ( 14274991 )
1963
41
The disordered physiology of obstructive bronchial disease. ( 13844453 )
1960
42
Bronchial disease and bronchography in pulmonary tuberculosis. ( 13560785 )
1958
43
Laboratory differentiation of chronic bronchial disease; an investigation of 117 cases. ( 13503231 )
1958
44
A correlated bronchographic and histopathologic study of bronchial disease in 216 tuberculous patients. ( 13313954 )
1956
45
Allergic bronchial disease. ( 13164601 )
1954
46
Bronchial disease in lungs resected for pulmonary tuberculosis. ( 13104881 )
1953
47
Bronchial disease in lungs resected for pulmonary tuberculosis. ( 13136317 )
1953

Variations for Bronchial Disease

Expression for Bronchial Disease

Search GEO for disease gene expression data for Bronchial Disease.

Pathways for Bronchial Disease

Pathways related to Bronchial Disease according to GeneCards Suite gene sharing:

(show all 31)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
14.01 CCL11 CXCL8 ELANE IFNGR1 IL13 IL33
2
Show member pathways
13.64 CCL11 CXCL8 IFNGR1 IL13 IL33 IL4
3
Show member pathways
13.49 AREG CCL11 CXCL8 IFNGR1 IL13 IL4
4
Show member pathways
13.38 AREG CCL11 CXCL8 IL13 IL4 IL5
5
Show member pathways
13.33 CCL11 CXCL8 IFNGR1 IL13 IL33 IL4
6
Show member pathways
13.28 AREG CCL11 CXCL8 FLNC IL13 IL4
7 12.82 CXCL8 IFNGR1 IL13 IL4 IL5 STAT6
8
Show member pathways
12.8 CCL11 CXCL8 IFNGR1 IL13 IL4 IL5
9
Show member pathways
12.77 CXCL8 IFNGR1 IL13 IL33 IL4 TLR9
10
Show member pathways
12.56 IL13 IL4 IL5 MS4A2 TNF
11
Show member pathways
12.52 CXCL8 IFNGR1 IL13 IL4 IL5 STAT6
12
Show member pathways
12.41 IFNGR1 IL13 IL4 IL5 STAT6 TNF
13
Show member pathways
12.3 CCL11 CXCL8 IL13 IL4 IL5 TNF
14
Show member pathways
12.18 IFNGR1 IL33 STAT6 TNF
15
Show member pathways
12.13 CCL11 CXCL8 IFNGR1 IL4 TLR9 TNF
16
Show member pathways
12.03 AREG CCL11 CXCL8 IFNGR1 IL13 IL4
17 11.9 CCL11 CXCL8 IL13 IL4 STAT6 TNF
18 11.81 IL4 IL5 TNF
19 11.81 CXCL8 IL13 IL4 IL5
20 11.76 CXCL8 FLNC IFNGR1
21
Show member pathways